Blood pressure level and relation to other cardiovascular risk factors in male hypertensive patients without clinical evidence of ischemic heart disease

Blood Pressure

Volumn 9, Issue 2-3, 2000, Pages 91-97

  Larsen, Carsten Toftager ^a,b   Sørum, Charlotte ^a   Hansen, Jørgen Fischer ^a   Jensen, Henrik Arenlund ^a   Rasmussen, Verner ^c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NONE

Author keywords

Arterial hypertension; Blood pressure; Cardiovascular risk factors

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; FAMILY HISTORY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034091482     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050050151780     Document Type: Article

References (28)

1. MRC-trial of treatment of mild hypertension. Br Med J 1985; 291: 97-104.
2. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971; 27: 335-46.
3. Kannel WB. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 1992; 13 Suppl D: 82-8.
4. Kannel WB, Gordon T, Castelli WP, Margolis TR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med 1970; 72: 813-22.
5. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham study. Ann Intern Med 1969; 71: 89-105.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli W. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Eng J Med 1990: 322: 1561-6.
7. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995; 9: 175-80.
8. Stampler J. Blood pressure and high blood pressure: aspects of risk. Hypertension 1991: 18 Suppl I: I-95-I-107.
9. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
10. White WB, Pickering TG, Morganroth et al. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991; 4: 890-6.
11. Strate M, Væth M, Harvald B. Twenty-one-year survival of primary hypertensive patients allocated to care in general practice or in specialized hypertension clinic. Blood Press 1997; 6: 88-95.
12. Cutler JA. High blood pressure and end-organ damage. J Hypertens 1996; 14: S3-S6.
13. Franklin SS, Gustin 4th W, Wong ND, Larson MG, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-15.
14. Timio M, Lippi G, Venanzi S, et al. Blood pressure trend and cardiovascular events in nuns in a secluded order: a 30-year follow up study. Blood Press 1997; 6: 81-7.
15. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-6.
16. Burt VL, Whelton PK, Rochella EJ, et al. Prevalence of hypertension in the US adult population: results from the third national health and nutrition examination survey, 1988-1991. Hypertension 1995; 25: 305-13.
17. Trenkwalder P, Ruland D, Slender et al. Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from Starnberg study on epidemiology of parkinsonism and hypertension in the elderly (STEPHY). J Hypertens 1994; 12: 709-16.
18. Hosie J, Wiklund I. Managing hypertension in general practice: can we do better? J Hum Hypertens 1995; 9: 515-18.
19. Stockwell DH, Madhavan S, Cohen H, Gibson G. Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Publ Health 1994: 84: 1768-74.
20. Mancia G, Sega R, Milesi C, Cesana G. Zanchetti A. Blood-pressure control in the hypertensive populations. Lancet 1997; 349: 454-7.
21. Chobian AV. Have long-term benefits of antihypertensive therapy been underestimated? Provocative findings from the Framingham Heart Study. Circulation 1996; 93: 638-40.
22. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cadiocascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996; 93: 697-703.
23. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-31.
24. Kaplan NM. Multiple risk factors for coronary heart disease in patients with hypertension. J Hypertens 1995; 13 Suppl: S1-S5.
25. Fletcher GF. The value of exercise in preventing coronary atherosclerotic heart disease. Heart Dis Stroke 1993: 2: 183-7.
26. SHEP Cooperative research group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program. JAMA 1991; 265: 3255-64.
27. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP Hypertension). Lancet 1991; 338: 1281-5.
28. Hansson L. Evaluation of endpoints in hypertension. Blood Press 1997; 6 Suppl 2: 76-80.